FRONT PHARMACOL 润色咨询

Frontiers in Pharmacology

出版年份:暂无数据 年文章数:13176 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:6.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1001972, encodeId=d43a10019e268, content=偏重的研究方向:神经疼痛<br>经验分享:投稿一天以后收到编辑部的邮件,请问这是什么意思,qPCR data, 尤其是染色的raw data, 我有几百张,都要给他们吗?邮件内容如下<br>Source data (raw data, original data, individual data points) for information presented in your tables and figures. This should be in a generally readable format and Excel files are preferred. <br>Full scans of the entire original gels displayed in your manuscript, the original files for any microscopy images or flow cytometry data (.fcs) included in your figures, and gating strategies for each flow experiment with clear labels to differentiate separate experiments., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12505517133, createdName=a大哈哈, createdTime=Fri Jul 23 12:22:48 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978987, encodeId=274c9e8987db, content=请问朋友们,frontiers in pharmacology已经接收,交完版面费并已经proof,一直没online,但2月后今天突然说要,拒稿! 朋友们帮帮提下意见!拜托!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12fe2483037, createdName=12461788m20(暂无昵称), createdTime=Fri Jul 02 13:26:36 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077702, encodeId=4e8d10e7702e8, content=审稿人1同意发表,审稿人2退出,20天没消息,什么个情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=49, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=有赵一日, createdTime=Tue Dec 07 11:33:45 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072900, encodeId=b31410e290039, content=偏重的研究方向:中药复方<br>经验分享:请问各位前辈们editorial assignment 需要多久?11月5日投稿,后让提交原始数据,现在还是editorial assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=ms6000001764055671, createdTime=Mon Nov 22 17:16:28 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963349, encodeId=cd53963349a0, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>偏重的研究方向:中药单体;肿瘤<br>经验分享:06 May 2021 Typesetting initiated.<br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>03 May 2021 Review of Review Editor 2 finalized.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>27 Apr 2021 Interactive review forum activated.<br>03 Apr 2021 Submitting Author submitted manuscript.<br>小硕一枚,赶在毕业前接收了文章,审稿人和编辑态度都很nice,给了小修,本来需要补实验,因为编辑时间给的短不能完成只好向审稿人说明了情况,并且认真回答了问题,修回后很快接收。第一次发英文文章,虽不太熟练,但总体下来比较顺利,希望各位在投的朋友们都能顺利中刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa8a5467299, createdName=ms7000000107906629, createdTime=Fri May 07 10:59:24 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179054, encodeId=120111e905462, content=偏重的研究方向:药理学<br>经验分享:总体比较顺利,中间有点小插曲。11月10号投稿,一天后收到索要原始数据邮件,把原始数据发过去又过了一天收到回复说可以继续送审,很快状态就变成了Review is Ongoing,这个状态好像很快Review is Ongoing就消失了,我在提交作者的账号中Inbox中就发现出了一个消息,有一份新的独立审稿报告已经提交了,并且可以看到审稿意见和评分。我考看了审稿人1的意见其实还行,但是评分很低,4项都是2分(满分5分),心想这下凉了。然后继续等着,过了几天Review is Ongoing又出现了,然后过了段时间又从下面变到上面,差不多到12月13号左右,我一登系统竟然直接跳过互动审稿,到了Review Finalized,仔细一看两个审稿人竟然都是Endorsed,但是各提了3个问题,上面说由于审稿人已经同意所以讨论框关闭了,邮件中说把答复写到Editor Tab中。花了两天时间兴冲冲得把答复写了,修改后的手稿传上去了,结果一直停在Review Finalized不动,显示等待编辑评估修改作最终结论,等了一周多我想是不是这个编辑忘了或者没有互动审稿他那边没有通知,我就发了邮件说修改后手稿已经提交顺祝圣诞快乐,结果一直没有任何回应,状态也没改变。直到12月27号,显示一个新的编辑撤销了原来的编辑并任命自己为客座编辑,然后他又激活了互动审稿,说得把回复的内容再让原来的两个审稿人审阅一下,我有点担心两个审稿人还能不能联系上,还愿不愿意再点一次。结果两个审稿人特别好,26号我上传了修改文件,并在互动审稿中回复了下,28号两个审稿人都回复Endorsed,显示Rev Finalized,29号时候Final validation差不多持续几个小时就顺利接收啦。前面看到小伙伴们说评分有没有影响,我觉得影响应该不太大,我的审稿人1给的8分(4项满分20),审稿人2给的10分(4项满分20),但是都给的Endorsed。还有就是编辑也很重要,如果在Review Finalized停留很长时间等待编辑评估修改做决定,有可能是编辑失联,可以给编辑部发邮件,撤换一个编辑可能就好了。另外,如果是提交作者账号,Inbox可能能提前看到审稿报告,可以提前准备回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Dec 31 07:32:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074570, encodeId=ad4210e457007, content=请教大家:The Associate Editor is evaluating any revisions made to the manuscript to take a final decision.这个阶段持续几天?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=researcher100, createdTime=Sat Nov 27 18:33:10 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964915, encodeId=335e964915e5, content=偏重的研究方向: 药理学 <br>经验分享:Review of Reviewer 0 is finalized是什么意思啊?有没有人知道。昨天历史记录出现了一个这。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bc95477957, createdName=ms3000000630263876, createdTime=Wed May 12 14:38:20 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951499, encodeId=21c695149975, content=停留在review finalized一周了,会不会被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7da75443507, createdName=ms2000001831846356, createdTime=Fri Mar 26 23:29:29 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950132, encodeId=d92a950132f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚开始投frontiers in medicine,后来initial validation 的时候编辑给转投了pharmacology这里。等待分配编辑的时间很漫长,从12月15号等待将近2月吧,也催过,但当有了编辑以后,审稿速度就很快了,独立审稿一个月后中修,之后返回后一周接受了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb995443418, createdName=冉紫彤, createdTime=Mon Mar 22 17:19:32 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
    2021-07-23 a大哈哈

    偏重的研究方向:神经疼痛
    经验分享:投稿一天以后收到编辑部的邮件,请问这是什么意思,qPCR data, 尤其是染色的raw data, 我有几百张,都要给他们吗?邮件内容如下
    Source data (raw data, original data, individual data points) for information presented in your tables and figures. This should be in a generally readable format and Excel files are preferred.
    Full scans of the entire original gels displayed in your manuscript, the original files for any microscopy images or flow cytometry data (.fcs) included in your figures, and gating strategies for each flow experiment with clear labels to differentiate separate experiments.

    69

    展开69条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1001972, encodeId=d43a10019e268, content=偏重的研究方向:神经疼痛<br>经验分享:投稿一天以后收到编辑部的邮件,请问这是什么意思,qPCR data, 尤其是染色的raw data, 我有几百张,都要给他们吗?邮件内容如下<br>Source data (raw data, original data, individual data points) for information presented in your tables and figures. This should be in a generally readable format and Excel files are preferred. <br>Full scans of the entire original gels displayed in your manuscript, the original files for any microscopy images or flow cytometry data (.fcs) included in your figures, and gating strategies for each flow experiment with clear labels to differentiate separate experiments., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12505517133, createdName=a大哈哈, createdTime=Fri Jul 23 12:22:48 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978987, encodeId=274c9e8987db, content=请问朋友们,frontiers in pharmacology已经接收,交完版面费并已经proof,一直没online,但2月后今天突然说要,拒稿! 朋友们帮帮提下意见!拜托!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12fe2483037, createdName=12461788m20(暂无昵称), createdTime=Fri Jul 02 13:26:36 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077702, encodeId=4e8d10e7702e8, content=审稿人1同意发表,审稿人2退出,20天没消息,什么个情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=49, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=有赵一日, createdTime=Tue Dec 07 11:33:45 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072900, encodeId=b31410e290039, content=偏重的研究方向:中药复方<br>经验分享:请问各位前辈们editorial assignment 需要多久?11月5日投稿,后让提交原始数据,现在还是editorial assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=ms6000001764055671, createdTime=Mon Nov 22 17:16:28 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963349, encodeId=cd53963349a0, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>偏重的研究方向:中药单体;肿瘤<br>经验分享:06 May 2021 Typesetting initiated.<br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>03 May 2021 Review of Review Editor 2 finalized.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>27 Apr 2021 Interactive review forum activated.<br>03 Apr 2021 Submitting Author submitted manuscript.<br>小硕一枚,赶在毕业前接收了文章,审稿人和编辑态度都很nice,给了小修,本来需要补实验,因为编辑时间给的短不能完成只好向审稿人说明了情况,并且认真回答了问题,修回后很快接收。第一次发英文文章,虽不太熟练,但总体下来比较顺利,希望各位在投的朋友们都能顺利中刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa8a5467299, createdName=ms7000000107906629, createdTime=Fri May 07 10:59:24 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179054, encodeId=120111e905462, content=偏重的研究方向:药理学<br>经验分享:总体比较顺利,中间有点小插曲。11月10号投稿,一天后收到索要原始数据邮件,把原始数据发过去又过了一天收到回复说可以继续送审,很快状态就变成了Review is Ongoing,这个状态好像很快Review is Ongoing就消失了,我在提交作者的账号中Inbox中就发现出了一个消息,有一份新的独立审稿报告已经提交了,并且可以看到审稿意见和评分。我考看了审稿人1的意见其实还行,但是评分很低,4项都是2分(满分5分),心想这下凉了。然后继续等着,过了几天Review is Ongoing又出现了,然后过了段时间又从下面变到上面,差不多到12月13号左右,我一登系统竟然直接跳过互动审稿,到了Review Finalized,仔细一看两个审稿人竟然都是Endorsed,但是各提了3个问题,上面说由于审稿人已经同意所以讨论框关闭了,邮件中说把答复写到Editor Tab中。花了两天时间兴冲冲得把答复写了,修改后的手稿传上去了,结果一直停在Review Finalized不动,显示等待编辑评估修改作最终结论,等了一周多我想是不是这个编辑忘了或者没有互动审稿他那边没有通知,我就发了邮件说修改后手稿已经提交顺祝圣诞快乐,结果一直没有任何回应,状态也没改变。直到12月27号,显示一个新的编辑撤销了原来的编辑并任命自己为客座编辑,然后他又激活了互动审稿,说得把回复的内容再让原来的两个审稿人审阅一下,我有点担心两个审稿人还能不能联系上,还愿不愿意再点一次。结果两个审稿人特别好,26号我上传了修改文件,并在互动审稿中回复了下,28号两个审稿人都回复Endorsed,显示Rev Finalized,29号时候Final validation差不多持续几个小时就顺利接收啦。前面看到小伙伴们说评分有没有影响,我觉得影响应该不太大,我的审稿人1给的8分(4项满分20),审稿人2给的10分(4项满分20),但是都给的Endorsed。还有就是编辑也很重要,如果在Review Finalized停留很长时间等待编辑评估修改做决定,有可能是编辑失联,可以给编辑部发邮件,撤换一个编辑可能就好了。另外,如果是提交作者账号,Inbox可能能提前看到审稿报告,可以提前准备回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Dec 31 07:32:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074570, encodeId=ad4210e457007, content=请教大家:The Associate Editor is evaluating any revisions made to the manuscript to take a final decision.这个阶段持续几天?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=researcher100, createdTime=Sat Nov 27 18:33:10 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964915, encodeId=335e964915e5, content=偏重的研究方向: 药理学 <br>经验分享:Review of Reviewer 0 is finalized是什么意思啊?有没有人知道。昨天历史记录出现了一个这。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bc95477957, createdName=ms3000000630263876, createdTime=Wed May 12 14:38:20 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951499, encodeId=21c695149975, content=停留在review finalized一周了,会不会被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7da75443507, createdName=ms2000001831846356, createdTime=Fri Mar 26 23:29:29 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950132, encodeId=d92a950132f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚开始投frontiers in medicine,后来initial validation 的时候编辑给转投了pharmacology这里。等待分配编辑的时间很漫长,从12月15号等待将近2月吧,也催过,但当有了编辑以后,审稿速度就很快了,独立审稿一个月后中修,之后返回后一周接受了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb995443418, createdName=冉紫彤, createdTime=Mon Mar 22 17:19:32 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
    2021-07-02 12461788m20(暂无昵称)

    请问朋友们,frontiers in pharmacology已经接收,交完版面费并已经proof,一直没online,但2月后今天突然说要,拒稿! 朋友们帮帮提下意见!拜托!

    51

    展开51条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1001972, encodeId=d43a10019e268, content=偏重的研究方向:神经疼痛<br>经验分享:投稿一天以后收到编辑部的邮件,请问这是什么意思,qPCR data, 尤其是染色的raw data, 我有几百张,都要给他们吗?邮件内容如下<br>Source data (raw data, original data, individual data points) for information presented in your tables and figures. This should be in a generally readable format and Excel files are preferred. <br>Full scans of the entire original gels displayed in your manuscript, the original files for any microscopy images or flow cytometry data (.fcs) included in your figures, and gating strategies for each flow experiment with clear labels to differentiate separate experiments., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12505517133, createdName=a大哈哈, createdTime=Fri Jul 23 12:22:48 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978987, encodeId=274c9e8987db, content=请问朋友们,frontiers in pharmacology已经接收,交完版面费并已经proof,一直没online,但2月后今天突然说要,拒稿! 朋友们帮帮提下意见!拜托!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12fe2483037, createdName=12461788m20(暂无昵称), createdTime=Fri Jul 02 13:26:36 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077702, encodeId=4e8d10e7702e8, content=审稿人1同意发表,审稿人2退出,20天没消息,什么个情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=49, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=有赵一日, createdTime=Tue Dec 07 11:33:45 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072900, encodeId=b31410e290039, content=偏重的研究方向:中药复方<br>经验分享:请问各位前辈们editorial assignment 需要多久?11月5日投稿,后让提交原始数据,现在还是editorial assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=ms6000001764055671, createdTime=Mon Nov 22 17:16:28 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963349, encodeId=cd53963349a0, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>偏重的研究方向:中药单体;肿瘤<br>经验分享:06 May 2021 Typesetting initiated.<br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>03 May 2021 Review of Review Editor 2 finalized.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>27 Apr 2021 Interactive review forum activated.<br>03 Apr 2021 Submitting Author submitted manuscript.<br>小硕一枚,赶在毕业前接收了文章,审稿人和编辑态度都很nice,给了小修,本来需要补实验,因为编辑时间给的短不能完成只好向审稿人说明了情况,并且认真回答了问题,修回后很快接收。第一次发英文文章,虽不太熟练,但总体下来比较顺利,希望各位在投的朋友们都能顺利中刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa8a5467299, createdName=ms7000000107906629, createdTime=Fri May 07 10:59:24 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179054, encodeId=120111e905462, content=偏重的研究方向:药理学<br>经验分享:总体比较顺利,中间有点小插曲。11月10号投稿,一天后收到索要原始数据邮件,把原始数据发过去又过了一天收到回复说可以继续送审,很快状态就变成了Review is Ongoing,这个状态好像很快Review is Ongoing就消失了,我在提交作者的账号中Inbox中就发现出了一个消息,有一份新的独立审稿报告已经提交了,并且可以看到审稿意见和评分。我考看了审稿人1的意见其实还行,但是评分很低,4项都是2分(满分5分),心想这下凉了。然后继续等着,过了几天Review is Ongoing又出现了,然后过了段时间又从下面变到上面,差不多到12月13号左右,我一登系统竟然直接跳过互动审稿,到了Review Finalized,仔细一看两个审稿人竟然都是Endorsed,但是各提了3个问题,上面说由于审稿人已经同意所以讨论框关闭了,邮件中说把答复写到Editor Tab中。花了两天时间兴冲冲得把答复写了,修改后的手稿传上去了,结果一直停在Review Finalized不动,显示等待编辑评估修改作最终结论,等了一周多我想是不是这个编辑忘了或者没有互动审稿他那边没有通知,我就发了邮件说修改后手稿已经提交顺祝圣诞快乐,结果一直没有任何回应,状态也没改变。直到12月27号,显示一个新的编辑撤销了原来的编辑并任命自己为客座编辑,然后他又激活了互动审稿,说得把回复的内容再让原来的两个审稿人审阅一下,我有点担心两个审稿人还能不能联系上,还愿不愿意再点一次。结果两个审稿人特别好,26号我上传了修改文件,并在互动审稿中回复了下,28号两个审稿人都回复Endorsed,显示Rev Finalized,29号时候Final validation差不多持续几个小时就顺利接收啦。前面看到小伙伴们说评分有没有影响,我觉得影响应该不太大,我的审稿人1给的8分(4项满分20),审稿人2给的10分(4项满分20),但是都给的Endorsed。还有就是编辑也很重要,如果在Review Finalized停留很长时间等待编辑评估修改做决定,有可能是编辑失联,可以给编辑部发邮件,撤换一个编辑可能就好了。另外,如果是提交作者账号,Inbox可能能提前看到审稿报告,可以提前准备回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Dec 31 07:32:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074570, encodeId=ad4210e457007, content=请教大家:The Associate Editor is evaluating any revisions made to the manuscript to take a final decision.这个阶段持续几天?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=researcher100, createdTime=Sat Nov 27 18:33:10 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964915, encodeId=335e964915e5, content=偏重的研究方向: 药理学 <br>经验分享:Review of Reviewer 0 is finalized是什么意思啊?有没有人知道。昨天历史记录出现了一个这。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bc95477957, createdName=ms3000000630263876, createdTime=Wed May 12 14:38:20 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951499, encodeId=21c695149975, content=停留在review finalized一周了,会不会被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7da75443507, createdName=ms2000001831846356, createdTime=Fri Mar 26 23:29:29 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950132, encodeId=d92a950132f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚开始投frontiers in medicine,后来initial validation 的时候编辑给转投了pharmacology这里。等待分配编辑的时间很漫长,从12月15号等待将近2月吧,也催过,但当有了编辑以后,审稿速度就很快了,独立审稿一个月后中修,之后返回后一周接受了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb995443418, createdName=冉紫彤, createdTime=Mon Mar 22 17:19:32 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
    2021-12-07 有赵一日

    审稿人1同意发表,审稿人2退出,20天没消息,什么个情况?

    49

    展开49条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1001972, encodeId=d43a10019e268, content=偏重的研究方向:神经疼痛<br>经验分享:投稿一天以后收到编辑部的邮件,请问这是什么意思,qPCR data, 尤其是染色的raw data, 我有几百张,都要给他们吗?邮件内容如下<br>Source data (raw data, original data, individual data points) for information presented in your tables and figures. This should be in a generally readable format and Excel files are preferred. <br>Full scans of the entire original gels displayed in your manuscript, the original files for any microscopy images or flow cytometry data (.fcs) included in your figures, and gating strategies for each flow experiment with clear labels to differentiate separate experiments., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12505517133, createdName=a大哈哈, createdTime=Fri Jul 23 12:22:48 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978987, encodeId=274c9e8987db, content=请问朋友们,frontiers in pharmacology已经接收,交完版面费并已经proof,一直没online,但2月后今天突然说要,拒稿! 朋友们帮帮提下意见!拜托!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12fe2483037, createdName=12461788m20(暂无昵称), createdTime=Fri Jul 02 13:26:36 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077702, encodeId=4e8d10e7702e8, content=审稿人1同意发表,审稿人2退出,20天没消息,什么个情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=49, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=有赵一日, createdTime=Tue Dec 07 11:33:45 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072900, encodeId=b31410e290039, content=偏重的研究方向:中药复方<br>经验分享:请问各位前辈们editorial assignment 需要多久?11月5日投稿,后让提交原始数据,现在还是editorial assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=ms6000001764055671, createdTime=Mon Nov 22 17:16:28 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963349, encodeId=cd53963349a0, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>偏重的研究方向:中药单体;肿瘤<br>经验分享:06 May 2021 Typesetting initiated.<br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>03 May 2021 Review of Review Editor 2 finalized.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>27 Apr 2021 Interactive review forum activated.<br>03 Apr 2021 Submitting Author submitted manuscript.<br>小硕一枚,赶在毕业前接收了文章,审稿人和编辑态度都很nice,给了小修,本来需要补实验,因为编辑时间给的短不能完成只好向审稿人说明了情况,并且认真回答了问题,修回后很快接收。第一次发英文文章,虽不太熟练,但总体下来比较顺利,希望各位在投的朋友们都能顺利中刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa8a5467299, createdName=ms7000000107906629, createdTime=Fri May 07 10:59:24 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179054, encodeId=120111e905462, content=偏重的研究方向:药理学<br>经验分享:总体比较顺利,中间有点小插曲。11月10号投稿,一天后收到索要原始数据邮件,把原始数据发过去又过了一天收到回复说可以继续送审,很快状态就变成了Review is Ongoing,这个状态好像很快Review is Ongoing就消失了,我在提交作者的账号中Inbox中就发现出了一个消息,有一份新的独立审稿报告已经提交了,并且可以看到审稿意见和评分。我考看了审稿人1的意见其实还行,但是评分很低,4项都是2分(满分5分),心想这下凉了。然后继续等着,过了几天Review is Ongoing又出现了,然后过了段时间又从下面变到上面,差不多到12月13号左右,我一登系统竟然直接跳过互动审稿,到了Review Finalized,仔细一看两个审稿人竟然都是Endorsed,但是各提了3个问题,上面说由于审稿人已经同意所以讨论框关闭了,邮件中说把答复写到Editor Tab中。花了两天时间兴冲冲得把答复写了,修改后的手稿传上去了,结果一直停在Review Finalized不动,显示等待编辑评估修改作最终结论,等了一周多我想是不是这个编辑忘了或者没有互动审稿他那边没有通知,我就发了邮件说修改后手稿已经提交顺祝圣诞快乐,结果一直没有任何回应,状态也没改变。直到12月27号,显示一个新的编辑撤销了原来的编辑并任命自己为客座编辑,然后他又激活了互动审稿,说得把回复的内容再让原来的两个审稿人审阅一下,我有点担心两个审稿人还能不能联系上,还愿不愿意再点一次。结果两个审稿人特别好,26号我上传了修改文件,并在互动审稿中回复了下,28号两个审稿人都回复Endorsed,显示Rev Finalized,29号时候Final validation差不多持续几个小时就顺利接收啦。前面看到小伙伴们说评分有没有影响,我觉得影响应该不太大,我的审稿人1给的8分(4项满分20),审稿人2给的10分(4项满分20),但是都给的Endorsed。还有就是编辑也很重要,如果在Review Finalized停留很长时间等待编辑评估修改做决定,有可能是编辑失联,可以给编辑部发邮件,撤换一个编辑可能就好了。另外,如果是提交作者账号,Inbox可能能提前看到审稿报告,可以提前准备回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Dec 31 07:32:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074570, encodeId=ad4210e457007, content=请教大家:The Associate Editor is evaluating any revisions made to the manuscript to take a final decision.这个阶段持续几天?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=researcher100, createdTime=Sat Nov 27 18:33:10 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964915, encodeId=335e964915e5, content=偏重的研究方向: 药理学 <br>经验分享:Review of Reviewer 0 is finalized是什么意思啊?有没有人知道。昨天历史记录出现了一个这。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bc95477957, createdName=ms3000000630263876, createdTime=Wed May 12 14:38:20 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951499, encodeId=21c695149975, content=停留在review finalized一周了,会不会被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7da75443507, createdName=ms2000001831846356, createdTime=Fri Mar 26 23:29:29 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950132, encodeId=d92a950132f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚开始投frontiers in medicine,后来initial validation 的时候编辑给转投了pharmacology这里。等待分配编辑的时间很漫长,从12月15号等待将近2月吧,也催过,但当有了编辑以后,审稿速度就很快了,独立审稿一个月后中修,之后返回后一周接受了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb995443418, createdName=冉紫彤, createdTime=Mon Mar 22 17:19:32 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
    2021-11-22 ms6000001764055671

    偏重的研究方向:中药复方
    经验分享:请问各位前辈们editorial assignment 需要多久?11月5日投稿,后让提交原始数据,现在还是editorial assignment状态

    41

    展开41条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1001972, encodeId=d43a10019e268, content=偏重的研究方向:神经疼痛<br>经验分享:投稿一天以后收到编辑部的邮件,请问这是什么意思,qPCR data, 尤其是染色的raw data, 我有几百张,都要给他们吗?邮件内容如下<br>Source data (raw data, original data, individual data points) for information presented in your tables and figures. This should be in a generally readable format and Excel files are preferred. <br>Full scans of the entire original gels displayed in your manuscript, the original files for any microscopy images or flow cytometry data (.fcs) included in your figures, and gating strategies for each flow experiment with clear labels to differentiate separate experiments., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12505517133, createdName=a大哈哈, createdTime=Fri Jul 23 12:22:48 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978987, encodeId=274c9e8987db, content=请问朋友们,frontiers in pharmacology已经接收,交完版面费并已经proof,一直没online,但2月后今天突然说要,拒稿! 朋友们帮帮提下意见!拜托!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12fe2483037, createdName=12461788m20(暂无昵称), createdTime=Fri Jul 02 13:26:36 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077702, encodeId=4e8d10e7702e8, content=审稿人1同意发表,审稿人2退出,20天没消息,什么个情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=49, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=有赵一日, createdTime=Tue Dec 07 11:33:45 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072900, encodeId=b31410e290039, content=偏重的研究方向:中药复方<br>经验分享:请问各位前辈们editorial assignment 需要多久?11月5日投稿,后让提交原始数据,现在还是editorial assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=ms6000001764055671, createdTime=Mon Nov 22 17:16:28 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963349, encodeId=cd53963349a0, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>偏重的研究方向:中药单体;肿瘤<br>经验分享:06 May 2021 Typesetting initiated.<br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>03 May 2021 Review of Review Editor 2 finalized.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>27 Apr 2021 Interactive review forum activated.<br>03 Apr 2021 Submitting Author submitted manuscript.<br>小硕一枚,赶在毕业前接收了文章,审稿人和编辑态度都很nice,给了小修,本来需要补实验,因为编辑时间给的短不能完成只好向审稿人说明了情况,并且认真回答了问题,修回后很快接收。第一次发英文文章,虽不太熟练,但总体下来比较顺利,希望各位在投的朋友们都能顺利中刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa8a5467299, createdName=ms7000000107906629, createdTime=Fri May 07 10:59:24 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179054, encodeId=120111e905462, content=偏重的研究方向:药理学<br>经验分享:总体比较顺利,中间有点小插曲。11月10号投稿,一天后收到索要原始数据邮件,把原始数据发过去又过了一天收到回复说可以继续送审,很快状态就变成了Review is Ongoing,这个状态好像很快Review is Ongoing就消失了,我在提交作者的账号中Inbox中就发现出了一个消息,有一份新的独立审稿报告已经提交了,并且可以看到审稿意见和评分。我考看了审稿人1的意见其实还行,但是评分很低,4项都是2分(满分5分),心想这下凉了。然后继续等着,过了几天Review is Ongoing又出现了,然后过了段时间又从下面变到上面,差不多到12月13号左右,我一登系统竟然直接跳过互动审稿,到了Review Finalized,仔细一看两个审稿人竟然都是Endorsed,但是各提了3个问题,上面说由于审稿人已经同意所以讨论框关闭了,邮件中说把答复写到Editor Tab中。花了两天时间兴冲冲得把答复写了,修改后的手稿传上去了,结果一直停在Review Finalized不动,显示等待编辑评估修改作最终结论,等了一周多我想是不是这个编辑忘了或者没有互动审稿他那边没有通知,我就发了邮件说修改后手稿已经提交顺祝圣诞快乐,结果一直没有任何回应,状态也没改变。直到12月27号,显示一个新的编辑撤销了原来的编辑并任命自己为客座编辑,然后他又激活了互动审稿,说得把回复的内容再让原来的两个审稿人审阅一下,我有点担心两个审稿人还能不能联系上,还愿不愿意再点一次。结果两个审稿人特别好,26号我上传了修改文件,并在互动审稿中回复了下,28号两个审稿人都回复Endorsed,显示Rev Finalized,29号时候Final validation差不多持续几个小时就顺利接收啦。前面看到小伙伴们说评分有没有影响,我觉得影响应该不太大,我的审稿人1给的8分(4项满分20),审稿人2给的10分(4项满分20),但是都给的Endorsed。还有就是编辑也很重要,如果在Review Finalized停留很长时间等待编辑评估修改做决定,有可能是编辑失联,可以给编辑部发邮件,撤换一个编辑可能就好了。另外,如果是提交作者账号,Inbox可能能提前看到审稿报告,可以提前准备回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Dec 31 07:32:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074570, encodeId=ad4210e457007, content=请教大家:The Associate Editor is evaluating any revisions made to the manuscript to take a final decision.这个阶段持续几天?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=researcher100, createdTime=Sat Nov 27 18:33:10 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964915, encodeId=335e964915e5, content=偏重的研究方向: 药理学 <br>经验分享:Review of Reviewer 0 is finalized是什么意思啊?有没有人知道。昨天历史记录出现了一个这。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bc95477957, createdName=ms3000000630263876, createdTime=Wed May 12 14:38:20 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951499, encodeId=21c695149975, content=停留在review finalized一周了,会不会被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7da75443507, createdName=ms2000001831846356, createdTime=Fri Mar 26 23:29:29 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950132, encodeId=d92a950132f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚开始投frontiers in medicine,后来initial validation 的时候编辑给转投了pharmacology这里。等待分配编辑的时间很漫长,从12月15号等待将近2月吧,也催过,但当有了编辑以后,审稿速度就很快了,独立审稿一个月后中修,之后返回后一周接受了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb995443418, createdName=冉紫彤, createdTime=Mon Mar 22 17:19:32 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
    2021-05-07 ms7000000107906629

    审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2950.0
    偏重的研究方向:中药单体;肿瘤
    经验分享:06 May 2021 Typesetting initiated.
    Article accepted for publication.
    Review of Review Editor 1 finalized.
    03 May 2021 Review of Review Editor 2 finalized.
    Submitting Author re-submitted manuscript.
    You posted new comments.
    27 Apr 2021 Interactive review forum activated.
    03 Apr 2021 Submitting Author submitted manuscript.
    小硕一枚,赶在毕业前接收了文章,审稿人和编辑态度都很nice,给了小修,本来需要补实验,因为编辑时间给的短不能完成只好向审稿人说明了情况,并且认真回答了问题,修回后很快接收。第一次发英文文章,虽不太熟练,但总体下来比较顺利,希望各位在投的朋友们都能顺利中刊~

    28

    展开28条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1001972, encodeId=d43a10019e268, content=偏重的研究方向:神经疼痛<br>经验分享:投稿一天以后收到编辑部的邮件,请问这是什么意思,qPCR data, 尤其是染色的raw data, 我有几百张,都要给他们吗?邮件内容如下<br>Source data (raw data, original data, individual data points) for information presented in your tables and figures. This should be in a generally readable format and Excel files are preferred. <br>Full scans of the entire original gels displayed in your manuscript, the original files for any microscopy images or flow cytometry data (.fcs) included in your figures, and gating strategies for each flow experiment with clear labels to differentiate separate experiments., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12505517133, createdName=a大哈哈, createdTime=Fri Jul 23 12:22:48 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978987, encodeId=274c9e8987db, content=请问朋友们,frontiers in pharmacology已经接收,交完版面费并已经proof,一直没online,但2月后今天突然说要,拒稿! 朋友们帮帮提下意见!拜托!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12fe2483037, createdName=12461788m20(暂无昵称), createdTime=Fri Jul 02 13:26:36 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077702, encodeId=4e8d10e7702e8, content=审稿人1同意发表,审稿人2退出,20天没消息,什么个情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=49, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=有赵一日, createdTime=Tue Dec 07 11:33:45 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072900, encodeId=b31410e290039, content=偏重的研究方向:中药复方<br>经验分享:请问各位前辈们editorial assignment 需要多久?11月5日投稿,后让提交原始数据,现在还是editorial assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=ms6000001764055671, createdTime=Mon Nov 22 17:16:28 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963349, encodeId=cd53963349a0, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>偏重的研究方向:中药单体;肿瘤<br>经验分享:06 May 2021 Typesetting initiated.<br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>03 May 2021 Review of Review Editor 2 finalized.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>27 Apr 2021 Interactive review forum activated.<br>03 Apr 2021 Submitting Author submitted manuscript.<br>小硕一枚,赶在毕业前接收了文章,审稿人和编辑态度都很nice,给了小修,本来需要补实验,因为编辑时间给的短不能完成只好向审稿人说明了情况,并且认真回答了问题,修回后很快接收。第一次发英文文章,虽不太熟练,但总体下来比较顺利,希望各位在投的朋友们都能顺利中刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa8a5467299, createdName=ms7000000107906629, createdTime=Fri May 07 10:59:24 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179054, encodeId=120111e905462, content=偏重的研究方向:药理学<br>经验分享:总体比较顺利,中间有点小插曲。11月10号投稿,一天后收到索要原始数据邮件,把原始数据发过去又过了一天收到回复说可以继续送审,很快状态就变成了Review is Ongoing,这个状态好像很快Review is Ongoing就消失了,我在提交作者的账号中Inbox中就发现出了一个消息,有一份新的独立审稿报告已经提交了,并且可以看到审稿意见和评分。我考看了审稿人1的意见其实还行,但是评分很低,4项都是2分(满分5分),心想这下凉了。然后继续等着,过了几天Review is Ongoing又出现了,然后过了段时间又从下面变到上面,差不多到12月13号左右,我一登系统竟然直接跳过互动审稿,到了Review Finalized,仔细一看两个审稿人竟然都是Endorsed,但是各提了3个问题,上面说由于审稿人已经同意所以讨论框关闭了,邮件中说把答复写到Editor Tab中。花了两天时间兴冲冲得把答复写了,修改后的手稿传上去了,结果一直停在Review Finalized不动,显示等待编辑评估修改作最终结论,等了一周多我想是不是这个编辑忘了或者没有互动审稿他那边没有通知,我就发了邮件说修改后手稿已经提交顺祝圣诞快乐,结果一直没有任何回应,状态也没改变。直到12月27号,显示一个新的编辑撤销了原来的编辑并任命自己为客座编辑,然后他又激活了互动审稿,说得把回复的内容再让原来的两个审稿人审阅一下,我有点担心两个审稿人还能不能联系上,还愿不愿意再点一次。结果两个审稿人特别好,26号我上传了修改文件,并在互动审稿中回复了下,28号两个审稿人都回复Endorsed,显示Rev Finalized,29号时候Final validation差不多持续几个小时就顺利接收啦。前面看到小伙伴们说评分有没有影响,我觉得影响应该不太大,我的审稿人1给的8分(4项满分20),审稿人2给的10分(4项满分20),但是都给的Endorsed。还有就是编辑也很重要,如果在Review Finalized停留很长时间等待编辑评估修改做决定,有可能是编辑失联,可以给编辑部发邮件,撤换一个编辑可能就好了。另外,如果是提交作者账号,Inbox可能能提前看到审稿报告,可以提前准备回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Dec 31 07:32:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074570, encodeId=ad4210e457007, content=请教大家:The Associate Editor is evaluating any revisions made to the manuscript to take a final decision.这个阶段持续几天?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=researcher100, createdTime=Sat Nov 27 18:33:10 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964915, encodeId=335e964915e5, content=偏重的研究方向: 药理学 <br>经验分享:Review of Reviewer 0 is finalized是什么意思啊?有没有人知道。昨天历史记录出现了一个这。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bc95477957, createdName=ms3000000630263876, createdTime=Wed May 12 14:38:20 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951499, encodeId=21c695149975, content=停留在review finalized一周了,会不会被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7da75443507, createdName=ms2000001831846356, createdTime=Fri Mar 26 23:29:29 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950132, encodeId=d92a950132f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚开始投frontiers in medicine,后来initial validation 的时候编辑给转投了pharmacology这里。等待分配编辑的时间很漫长,从12月15号等待将近2月吧,也催过,但当有了编辑以后,审稿速度就很快了,独立审稿一个月后中修,之后返回后一周接受了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb995443418, createdName=冉紫彤, createdTime=Mon Mar 22 17:19:32 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
    2021-12-31 ay

    偏重的研究方向:药理学
    经验分享:总体比较顺利,中间有点小插曲。11月10号投稿,一天后收到索要原始数据邮件,把原始数据发过去又过了一天收到回复说可以继续送审,很快状态就变成了Review is Ongoing,这个状态好像很快Review is Ongoing就消失了,我在提交作者的账号中Inbox中就发现出了一个消息,有一份新的独立审稿报告已经提交了,并且可以看到审稿意见和评分。我考看了审稿人1的意见其实还行,但是评分很低,4项都是2分(满分5分),心想这下凉了。然后继续等着,过了几天Review is Ongoing又出现了,然后过了段时间又从下面变到上面,差不多到12月13号左右,我一登系统竟然直接跳过互动审稿,到了Review Finalized,仔细一看两个审稿人竟然都是Endorsed,但是各提了3个问题,上面说由于审稿人已经同意所以讨论框关闭了,邮件中说把答复写到Editor Tab中。花了两天时间兴冲冲得把答复写了,修改后的手稿传上去了,结果一直停在Review Finalized不动,显示等待编辑评估修改作最终结论,等了一周多我想是不是这个编辑忘了或者没有互动审稿他那边没有通知,我就发了邮件说修改后手稿已经提交顺祝圣诞快乐,结果一直没有任何回应,状态也没改变。直到12月27号,显示一个新的编辑撤销了原来的编辑并任命自己为客座编辑,然后他又激活了互动审稿,说得把回复的内容再让原来的两个审稿人审阅一下,我有点担心两个审稿人还能不能联系上,还愿不愿意再点一次。结果两个审稿人特别好,26号我上传了修改文件,并在互动审稿中回复了下,28号两个审稿人都回复Endorsed,显示Rev Finalized,29号时候Final validation差不多持续几个小时就顺利接收啦。前面看到小伙伴们说评分有没有影响,我觉得影响应该不太大,我的审稿人1给的8分(4项满分20),审稿人2给的10分(4项满分20),但是都给的Endorsed。还有就是编辑也很重要,如果在Review Finalized停留很长时间等待编辑评估修改做决定,有可能是编辑失联,可以给编辑部发邮件,撤换一个编辑可能就好了。另外,如果是提交作者账号,Inbox可能能提前看到审稿报告,可以提前准备回复。

    23

    展开23条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1001972, encodeId=d43a10019e268, content=偏重的研究方向:神经疼痛<br>经验分享:投稿一天以后收到编辑部的邮件,请问这是什么意思,qPCR data, 尤其是染色的raw data, 我有几百张,都要给他们吗?邮件内容如下<br>Source data (raw data, original data, individual data points) for information presented in your tables and figures. This should be in a generally readable format and Excel files are preferred. <br>Full scans of the entire original gels displayed in your manuscript, the original files for any microscopy images or flow cytometry data (.fcs) included in your figures, and gating strategies for each flow experiment with clear labels to differentiate separate experiments., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12505517133, createdName=a大哈哈, createdTime=Fri Jul 23 12:22:48 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978987, encodeId=274c9e8987db, content=请问朋友们,frontiers in pharmacology已经接收,交完版面费并已经proof,一直没online,但2月后今天突然说要,拒稿! 朋友们帮帮提下意见!拜托!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12fe2483037, createdName=12461788m20(暂无昵称), createdTime=Fri Jul 02 13:26:36 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077702, encodeId=4e8d10e7702e8, content=审稿人1同意发表,审稿人2退出,20天没消息,什么个情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=49, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=有赵一日, createdTime=Tue Dec 07 11:33:45 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072900, encodeId=b31410e290039, content=偏重的研究方向:中药复方<br>经验分享:请问各位前辈们editorial assignment 需要多久?11月5日投稿,后让提交原始数据,现在还是editorial assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=ms6000001764055671, createdTime=Mon Nov 22 17:16:28 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963349, encodeId=cd53963349a0, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>偏重的研究方向:中药单体;肿瘤<br>经验分享:06 May 2021 Typesetting initiated.<br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>03 May 2021 Review of Review Editor 2 finalized.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>27 Apr 2021 Interactive review forum activated.<br>03 Apr 2021 Submitting Author submitted manuscript.<br>小硕一枚,赶在毕业前接收了文章,审稿人和编辑态度都很nice,给了小修,本来需要补实验,因为编辑时间给的短不能完成只好向审稿人说明了情况,并且认真回答了问题,修回后很快接收。第一次发英文文章,虽不太熟练,但总体下来比较顺利,希望各位在投的朋友们都能顺利中刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa8a5467299, createdName=ms7000000107906629, createdTime=Fri May 07 10:59:24 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179054, encodeId=120111e905462, content=偏重的研究方向:药理学<br>经验分享:总体比较顺利,中间有点小插曲。11月10号投稿,一天后收到索要原始数据邮件,把原始数据发过去又过了一天收到回复说可以继续送审,很快状态就变成了Review is Ongoing,这个状态好像很快Review is Ongoing就消失了,我在提交作者的账号中Inbox中就发现出了一个消息,有一份新的独立审稿报告已经提交了,并且可以看到审稿意见和评分。我考看了审稿人1的意见其实还行,但是评分很低,4项都是2分(满分5分),心想这下凉了。然后继续等着,过了几天Review is Ongoing又出现了,然后过了段时间又从下面变到上面,差不多到12月13号左右,我一登系统竟然直接跳过互动审稿,到了Review Finalized,仔细一看两个审稿人竟然都是Endorsed,但是各提了3个问题,上面说由于审稿人已经同意所以讨论框关闭了,邮件中说把答复写到Editor Tab中。花了两天时间兴冲冲得把答复写了,修改后的手稿传上去了,结果一直停在Review Finalized不动,显示等待编辑评估修改作最终结论,等了一周多我想是不是这个编辑忘了或者没有互动审稿他那边没有通知,我就发了邮件说修改后手稿已经提交顺祝圣诞快乐,结果一直没有任何回应,状态也没改变。直到12月27号,显示一个新的编辑撤销了原来的编辑并任命自己为客座编辑,然后他又激活了互动审稿,说得把回复的内容再让原来的两个审稿人审阅一下,我有点担心两个审稿人还能不能联系上,还愿不愿意再点一次。结果两个审稿人特别好,26号我上传了修改文件,并在互动审稿中回复了下,28号两个审稿人都回复Endorsed,显示Rev Finalized,29号时候Final validation差不多持续几个小时就顺利接收啦。前面看到小伙伴们说评分有没有影响,我觉得影响应该不太大,我的审稿人1给的8分(4项满分20),审稿人2给的10分(4项满分20),但是都给的Endorsed。还有就是编辑也很重要,如果在Review Finalized停留很长时间等待编辑评估修改做决定,有可能是编辑失联,可以给编辑部发邮件,撤换一个编辑可能就好了。另外,如果是提交作者账号,Inbox可能能提前看到审稿报告,可以提前准备回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Dec 31 07:32:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074570, encodeId=ad4210e457007, content=请教大家:The Associate Editor is evaluating any revisions made to the manuscript to take a final decision.这个阶段持续几天?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=researcher100, createdTime=Sat Nov 27 18:33:10 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964915, encodeId=335e964915e5, content=偏重的研究方向: 药理学 <br>经验分享:Review of Reviewer 0 is finalized是什么意思啊?有没有人知道。昨天历史记录出现了一个这。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bc95477957, createdName=ms3000000630263876, createdTime=Wed May 12 14:38:20 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951499, encodeId=21c695149975, content=停留在review finalized一周了,会不会被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7da75443507, createdName=ms2000001831846356, createdTime=Fri Mar 26 23:29:29 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950132, encodeId=d92a950132f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚开始投frontiers in medicine,后来initial validation 的时候编辑给转投了pharmacology这里。等待分配编辑的时间很漫长,从12月15号等待将近2月吧,也催过,但当有了编辑以后,审稿速度就很快了,独立审稿一个月后中修,之后返回后一周接受了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb995443418, createdName=冉紫彤, createdTime=Mon Mar 22 17:19:32 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
    2021-11-27 researcher100

    请教大家:The Associate Editor is evaluating any revisions made to the manuscript to take a final decision.这个阶段持续几天?谢谢!

    21

    展开21条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1001972, encodeId=d43a10019e268, content=偏重的研究方向:神经疼痛<br>经验分享:投稿一天以后收到编辑部的邮件,请问这是什么意思,qPCR data, 尤其是染色的raw data, 我有几百张,都要给他们吗?邮件内容如下<br>Source data (raw data, original data, individual data points) for information presented in your tables and figures. This should be in a generally readable format and Excel files are preferred. <br>Full scans of the entire original gels displayed in your manuscript, the original files for any microscopy images or flow cytometry data (.fcs) included in your figures, and gating strategies for each flow experiment with clear labels to differentiate separate experiments., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12505517133, createdName=a大哈哈, createdTime=Fri Jul 23 12:22:48 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978987, encodeId=274c9e8987db, content=请问朋友们,frontiers in pharmacology已经接收,交完版面费并已经proof,一直没online,但2月后今天突然说要,拒稿! 朋友们帮帮提下意见!拜托!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12fe2483037, createdName=12461788m20(暂无昵称), createdTime=Fri Jul 02 13:26:36 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077702, encodeId=4e8d10e7702e8, content=审稿人1同意发表,审稿人2退出,20天没消息,什么个情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=49, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=有赵一日, createdTime=Tue Dec 07 11:33:45 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072900, encodeId=b31410e290039, content=偏重的研究方向:中药复方<br>经验分享:请问各位前辈们editorial assignment 需要多久?11月5日投稿,后让提交原始数据,现在还是editorial assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=ms6000001764055671, createdTime=Mon Nov 22 17:16:28 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963349, encodeId=cd53963349a0, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>偏重的研究方向:中药单体;肿瘤<br>经验分享:06 May 2021 Typesetting initiated.<br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>03 May 2021 Review of Review Editor 2 finalized.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>27 Apr 2021 Interactive review forum activated.<br>03 Apr 2021 Submitting Author submitted manuscript.<br>小硕一枚,赶在毕业前接收了文章,审稿人和编辑态度都很nice,给了小修,本来需要补实验,因为编辑时间给的短不能完成只好向审稿人说明了情况,并且认真回答了问题,修回后很快接收。第一次发英文文章,虽不太熟练,但总体下来比较顺利,希望各位在投的朋友们都能顺利中刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa8a5467299, createdName=ms7000000107906629, createdTime=Fri May 07 10:59:24 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179054, encodeId=120111e905462, content=偏重的研究方向:药理学<br>经验分享:总体比较顺利,中间有点小插曲。11月10号投稿,一天后收到索要原始数据邮件,把原始数据发过去又过了一天收到回复说可以继续送审,很快状态就变成了Review is Ongoing,这个状态好像很快Review is Ongoing就消失了,我在提交作者的账号中Inbox中就发现出了一个消息,有一份新的独立审稿报告已经提交了,并且可以看到审稿意见和评分。我考看了审稿人1的意见其实还行,但是评分很低,4项都是2分(满分5分),心想这下凉了。然后继续等着,过了几天Review is Ongoing又出现了,然后过了段时间又从下面变到上面,差不多到12月13号左右,我一登系统竟然直接跳过互动审稿,到了Review Finalized,仔细一看两个审稿人竟然都是Endorsed,但是各提了3个问题,上面说由于审稿人已经同意所以讨论框关闭了,邮件中说把答复写到Editor Tab中。花了两天时间兴冲冲得把答复写了,修改后的手稿传上去了,结果一直停在Review Finalized不动,显示等待编辑评估修改作最终结论,等了一周多我想是不是这个编辑忘了或者没有互动审稿他那边没有通知,我就发了邮件说修改后手稿已经提交顺祝圣诞快乐,结果一直没有任何回应,状态也没改变。直到12月27号,显示一个新的编辑撤销了原来的编辑并任命自己为客座编辑,然后他又激活了互动审稿,说得把回复的内容再让原来的两个审稿人审阅一下,我有点担心两个审稿人还能不能联系上,还愿不愿意再点一次。结果两个审稿人特别好,26号我上传了修改文件,并在互动审稿中回复了下,28号两个审稿人都回复Endorsed,显示Rev Finalized,29号时候Final validation差不多持续几个小时就顺利接收啦。前面看到小伙伴们说评分有没有影响,我觉得影响应该不太大,我的审稿人1给的8分(4项满分20),审稿人2给的10分(4项满分20),但是都给的Endorsed。还有就是编辑也很重要,如果在Review Finalized停留很长时间等待编辑评估修改做决定,有可能是编辑失联,可以给编辑部发邮件,撤换一个编辑可能就好了。另外,如果是提交作者账号,Inbox可能能提前看到审稿报告,可以提前准备回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Dec 31 07:32:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074570, encodeId=ad4210e457007, content=请教大家:The Associate Editor is evaluating any revisions made to the manuscript to take a final decision.这个阶段持续几天?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=researcher100, createdTime=Sat Nov 27 18:33:10 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964915, encodeId=335e964915e5, content=偏重的研究方向: 药理学 <br>经验分享:Review of Reviewer 0 is finalized是什么意思啊?有没有人知道。昨天历史记录出现了一个这。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bc95477957, createdName=ms3000000630263876, createdTime=Wed May 12 14:38:20 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951499, encodeId=21c695149975, content=停留在review finalized一周了,会不会被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7da75443507, createdName=ms2000001831846356, createdTime=Fri Mar 26 23:29:29 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950132, encodeId=d92a950132f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚开始投frontiers in medicine,后来initial validation 的时候编辑给转投了pharmacology这里。等待分配编辑的时间很漫长,从12月15号等待将近2月吧,也催过,但当有了编辑以后,审稿速度就很快了,独立审稿一个月后中修,之后返回后一周接受了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb995443418, createdName=冉紫彤, createdTime=Mon Mar 22 17:19:32 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
    2021-05-12 ms3000000630263876

    偏重的研究方向: 药理学
    经验分享:Review of Reviewer 0 is finalized是什么意思啊?有没有人知道。昨天历史记录出现了一个这。

    21

    展开21条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1001972, encodeId=d43a10019e268, content=偏重的研究方向:神经疼痛<br>经验分享:投稿一天以后收到编辑部的邮件,请问这是什么意思,qPCR data, 尤其是染色的raw data, 我有几百张,都要给他们吗?邮件内容如下<br>Source data (raw data, original data, individual data points) for information presented in your tables and figures. This should be in a generally readable format and Excel files are preferred. <br>Full scans of the entire original gels displayed in your manuscript, the original files for any microscopy images or flow cytometry data (.fcs) included in your figures, and gating strategies for each flow experiment with clear labels to differentiate separate experiments., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12505517133, createdName=a大哈哈, createdTime=Fri Jul 23 12:22:48 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978987, encodeId=274c9e8987db, content=请问朋友们,frontiers in pharmacology已经接收,交完版面费并已经proof,一直没online,但2月后今天突然说要,拒稿! 朋友们帮帮提下意见!拜托!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12fe2483037, createdName=12461788m20(暂无昵称), createdTime=Fri Jul 02 13:26:36 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077702, encodeId=4e8d10e7702e8, content=审稿人1同意发表,审稿人2退出,20天没消息,什么个情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=49, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=有赵一日, createdTime=Tue Dec 07 11:33:45 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072900, encodeId=b31410e290039, content=偏重的研究方向:中药复方<br>经验分享:请问各位前辈们editorial assignment 需要多久?11月5日投稿,后让提交原始数据,现在还是editorial assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=ms6000001764055671, createdTime=Mon Nov 22 17:16:28 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963349, encodeId=cd53963349a0, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>偏重的研究方向:中药单体;肿瘤<br>经验分享:06 May 2021 Typesetting initiated.<br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>03 May 2021 Review of Review Editor 2 finalized.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>27 Apr 2021 Interactive review forum activated.<br>03 Apr 2021 Submitting Author submitted manuscript.<br>小硕一枚,赶在毕业前接收了文章,审稿人和编辑态度都很nice,给了小修,本来需要补实验,因为编辑时间给的短不能完成只好向审稿人说明了情况,并且认真回答了问题,修回后很快接收。第一次发英文文章,虽不太熟练,但总体下来比较顺利,希望各位在投的朋友们都能顺利中刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa8a5467299, createdName=ms7000000107906629, createdTime=Fri May 07 10:59:24 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179054, encodeId=120111e905462, content=偏重的研究方向:药理学<br>经验分享:总体比较顺利,中间有点小插曲。11月10号投稿,一天后收到索要原始数据邮件,把原始数据发过去又过了一天收到回复说可以继续送审,很快状态就变成了Review is Ongoing,这个状态好像很快Review is Ongoing就消失了,我在提交作者的账号中Inbox中就发现出了一个消息,有一份新的独立审稿报告已经提交了,并且可以看到审稿意见和评分。我考看了审稿人1的意见其实还行,但是评分很低,4项都是2分(满分5分),心想这下凉了。然后继续等着,过了几天Review is Ongoing又出现了,然后过了段时间又从下面变到上面,差不多到12月13号左右,我一登系统竟然直接跳过互动审稿,到了Review Finalized,仔细一看两个审稿人竟然都是Endorsed,但是各提了3个问题,上面说由于审稿人已经同意所以讨论框关闭了,邮件中说把答复写到Editor Tab中。花了两天时间兴冲冲得把答复写了,修改后的手稿传上去了,结果一直停在Review Finalized不动,显示等待编辑评估修改作最终结论,等了一周多我想是不是这个编辑忘了或者没有互动审稿他那边没有通知,我就发了邮件说修改后手稿已经提交顺祝圣诞快乐,结果一直没有任何回应,状态也没改变。直到12月27号,显示一个新的编辑撤销了原来的编辑并任命自己为客座编辑,然后他又激活了互动审稿,说得把回复的内容再让原来的两个审稿人审阅一下,我有点担心两个审稿人还能不能联系上,还愿不愿意再点一次。结果两个审稿人特别好,26号我上传了修改文件,并在互动审稿中回复了下,28号两个审稿人都回复Endorsed,显示Rev Finalized,29号时候Final validation差不多持续几个小时就顺利接收啦。前面看到小伙伴们说评分有没有影响,我觉得影响应该不太大,我的审稿人1给的8分(4项满分20),审稿人2给的10分(4项满分20),但是都给的Endorsed。还有就是编辑也很重要,如果在Review Finalized停留很长时间等待编辑评估修改做决定,有可能是编辑失联,可以给编辑部发邮件,撤换一个编辑可能就好了。另外,如果是提交作者账号,Inbox可能能提前看到审稿报告,可以提前准备回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Dec 31 07:32:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074570, encodeId=ad4210e457007, content=请教大家:The Associate Editor is evaluating any revisions made to the manuscript to take a final decision.这个阶段持续几天?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=researcher100, createdTime=Sat Nov 27 18:33:10 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964915, encodeId=335e964915e5, content=偏重的研究方向: 药理学 <br>经验分享:Review of Reviewer 0 is finalized是什么意思啊?有没有人知道。昨天历史记录出现了一个这。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bc95477957, createdName=ms3000000630263876, createdTime=Wed May 12 14:38:20 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951499, encodeId=21c695149975, content=停留在review finalized一周了,会不会被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7da75443507, createdName=ms2000001831846356, createdTime=Fri Mar 26 23:29:29 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950132, encodeId=d92a950132f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚开始投frontiers in medicine,后来initial validation 的时候编辑给转投了pharmacology这里。等待分配编辑的时间很漫长,从12月15号等待将近2月吧,也催过,但当有了编辑以后,审稿速度就很快了,独立审稿一个月后中修,之后返回后一周接受了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb995443418, createdName=冉紫彤, createdTime=Mon Mar 22 17:19:32 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
    2021-03-26 ms2000001831846356

    停留在review finalized一周了,会不会被拒啊

    21

    展开21条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1001972, encodeId=d43a10019e268, content=偏重的研究方向:神经疼痛<br>经验分享:投稿一天以后收到编辑部的邮件,请问这是什么意思,qPCR data, 尤其是染色的raw data, 我有几百张,都要给他们吗?邮件内容如下<br>Source data (raw data, original data, individual data points) for information presented in your tables and figures. This should be in a generally readable format and Excel files are preferred. <br>Full scans of the entire original gels displayed in your manuscript, the original files for any microscopy images or flow cytometry data (.fcs) included in your figures, and gating strategies for each flow experiment with clear labels to differentiate separate experiments., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12505517133, createdName=a大哈哈, createdTime=Fri Jul 23 12:22:48 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978987, encodeId=274c9e8987db, content=请问朋友们,frontiers in pharmacology已经接收,交完版面费并已经proof,一直没online,但2月后今天突然说要,拒稿! 朋友们帮帮提下意见!拜托!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=12fe2483037, createdName=12461788m20(暂无昵称), createdTime=Fri Jul 02 13:26:36 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077702, encodeId=4e8d10e7702e8, content=审稿人1同意发表,审稿人2退出,20天没消息,什么个情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=49, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=有赵一日, createdTime=Tue Dec 07 11:33:45 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072900, encodeId=b31410e290039, content=偏重的研究方向:中药复方<br>经验分享:请问各位前辈们editorial assignment 需要多久?11月5日投稿,后让提交原始数据,现在还是editorial assignment状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=ms6000001764055671, createdTime=Mon Nov 22 17:16:28 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963349, encodeId=cd53963349a0, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>偏重的研究方向:中药单体;肿瘤<br>经验分享:06 May 2021 Typesetting initiated.<br>Article accepted for publication.<br>Review of Review Editor 1 finalized.<br>03 May 2021 Review of Review Editor 2 finalized.<br>Submitting Author re-submitted manuscript.<br>You posted new comments.<br>27 Apr 2021 Interactive review forum activated.<br>03 Apr 2021 Submitting Author submitted manuscript.<br>小硕一枚,赶在毕业前接收了文章,审稿人和编辑态度都很nice,给了小修,本来需要补实验,因为编辑时间给的短不能完成只好向审稿人说明了情况,并且认真回答了问题,修回后很快接收。第一次发英文文章,虽不太熟练,但总体下来比较顺利,希望各位在投的朋友们都能顺利中刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa8a5467299, createdName=ms7000000107906629, createdTime=Fri May 07 10:59:24 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179054, encodeId=120111e905462, content=偏重的研究方向:药理学<br>经验分享:总体比较顺利,中间有点小插曲。11月10号投稿,一天后收到索要原始数据邮件,把原始数据发过去又过了一天收到回复说可以继续送审,很快状态就变成了Review is Ongoing,这个状态好像很快Review is Ongoing就消失了,我在提交作者的账号中Inbox中就发现出了一个消息,有一份新的独立审稿报告已经提交了,并且可以看到审稿意见和评分。我考看了审稿人1的意见其实还行,但是评分很低,4项都是2分(满分5分),心想这下凉了。然后继续等着,过了几天Review is Ongoing又出现了,然后过了段时间又从下面变到上面,差不多到12月13号左右,我一登系统竟然直接跳过互动审稿,到了Review Finalized,仔细一看两个审稿人竟然都是Endorsed,但是各提了3个问题,上面说由于审稿人已经同意所以讨论框关闭了,邮件中说把答复写到Editor Tab中。花了两天时间兴冲冲得把答复写了,修改后的手稿传上去了,结果一直停在Review Finalized不动,显示等待编辑评估修改作最终结论,等了一周多我想是不是这个编辑忘了或者没有互动审稿他那边没有通知,我就发了邮件说修改后手稿已经提交顺祝圣诞快乐,结果一直没有任何回应,状态也没改变。直到12月27号,显示一个新的编辑撤销了原来的编辑并任命自己为客座编辑,然后他又激活了互动审稿,说得把回复的内容再让原来的两个审稿人审阅一下,我有点担心两个审稿人还能不能联系上,还愿不愿意再点一次。结果两个审稿人特别好,26号我上传了修改文件,并在互动审稿中回复了下,28号两个审稿人都回复Endorsed,显示Rev Finalized,29号时候Final validation差不多持续几个小时就顺利接收啦。前面看到小伙伴们说评分有没有影响,我觉得影响应该不太大,我的审稿人1给的8分(4项满分20),审稿人2给的10分(4项满分20),但是都给的Endorsed。还有就是编辑也很重要,如果在Review Finalized停留很长时间等待编辑评估修改做决定,有可能是编辑失联,可以给编辑部发邮件,撤换一个编辑可能就好了。另外,如果是提交作者账号,Inbox可能能提前看到审稿报告,可以提前准备回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Dec 31 07:32:40 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074570, encodeId=ad4210e457007, content=请教大家:The Associate Editor is evaluating any revisions made to the manuscript to take a final decision.这个阶段持续几天?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=researcher100, createdTime=Sat Nov 27 18:33:10 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964915, encodeId=335e964915e5, content=偏重的研究方向: 药理学 <br>经验分享:Review of Reviewer 0 is finalized是什么意思啊?有没有人知道。昨天历史记录出现了一个这。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bc95477957, createdName=ms3000000630263876, createdTime=Wed May 12 14:38:20 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951499, encodeId=21c695149975, content=停留在review finalized一周了,会不会被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7da75443507, createdName=ms2000001831846356, createdTime=Fri Mar 26 23:29:29 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950132, encodeId=d92a950132f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚开始投frontiers in medicine,后来initial validation 的时候编辑给转投了pharmacology这里。等待分配编辑的时间很漫长,从12月15号等待将近2月吧,也催过,但当有了编辑以后,审稿速度就很快了,独立审稿一个月后中修,之后返回后一周接受了! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb995443418, createdName=冉紫彤, createdTime=Mon Mar 22 17:19:32 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
    2021-03-22 冉紫彤

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:刚开始投frontiers in medicine,后来initial validation 的时候编辑给转投了pharmacology这里。等待分配编辑的时间很漫长,从12月15号等待将近2月吧,也催过,但当有了编辑以后,审稿速度就很快了,独立审稿一个月后中修,之后返回后一周接受了!

    19

    展开19条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分